| Testcode: | E_CGA_S |
| Specimens: | 300 µl Serum (s), frozen |
| Preanalytics/Notes: |
|
| Method: | TRACE assay |
| Dimension: | µg/l |
| Set-up: | Mon Tue Wed Thu Fri Sat Sun |
| Duration: | 1 day |
| Indication/Significance: |
|
| Interpretation: |
Increased: In the case more… Increased: In the case of phaeochromocytomas (sensitivity 83 %, specificity 96 %) High levels indicate that the tumour originated in neuroendocrine tissue. Occurrence in neuroendocrine cells, phaeochromocytomas, carcinoids and all tumours which synthesise peptide hormones, e.g. hyperparathyroidism, C-cell carcinoma, islet-cell tumour, pituitary tumour, bronchial carcinoma, endocrine cells of the intestine. Neuroendocrine prostate cancer (often develops with androgen deprivation therapy of prostate cancer, associated with poor prognosis). In patients suffering from renal insufficiency. In patients suffering from cardiac insufficiency, elevated values may reach the blood also from the ventricular myocardium.
|
performance by Bioscientia medical service centers
| both sex | ||
|---|---|---|
| < 102 µg/l | ||
Die Kosten werden für den i. d. R. genutzten 1,15-fachen GOÄ-Satz dargestellt. Wird die Untersuchung nicht in Ihrem regionalen Labor durchgeführt, erfolgt die Analyse in dem Labor, das im Leistungsverzeichnis genannt ist. In diesem Fall gilt der dort für die Untersuchung angegebene Preis.